α-adrenergic stimulation enhances inducible nitric oxide synthase expression in rat cardiac myocytes

Journal of Molecular and Cellular Cardiology

Volumn 28, Issue 7, 1996, Pages 1539-1545

  Ikeda, Uichi ^a   Murakami, Yoshiaki ^a   Kanbe, Toshiko ^a   Shimada, Kazuyuki ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Interleukin 1; Nitrite; Phenylephrine; Protein kinase C; adrenergic receptor

Indexed keywords

ARGININE DERIVATIVE; CALPHOSTIN C; DACTINOMYCIN; INTERLEUKIN 1BETA; MESSENGER RNA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRITE; PHENYLEPHRINE; PHORBOL 12 ACETATE 13 MYRISTATE; PROTEIN KINASE C;

ALPHA ADRENERGIC STIMULATION; ANIMAL CELL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME ACTIVITY; HEART MUSCLE CELL; NEWBORN; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALIA;

EID: 0030199026     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1996.0144     Document Type: Article

References (43)

1. BALLIGAND JL, KELLY RA, MARSDEN PA, SMITH TW, MICHEL T, 1993. Control of cardiac muscle cell function by an endogenous nitric oxide signaling system. Proc Natl Acad Sci USA 90: 347-351.
2. BENEEY RG, 1993. Function of myocardial α-adrenoceptors. J Auton Pharmocol 13: 351-372.
3. BRADY AJB, POOLE-WILSON PA, HARDING SE, WARREN JB, 1992. Nitric oxide production within cardiac myocytes reduces their contractility in endotoxiemia. Am J Physiol 263: 1963-1966.
4. BRADY AJB, WARREN PA, POOLE-WILSON PA, WILLIAMS TJ, HARDING SE, 1993. Nitric oxide attenuates cardiac myocyte contraction. Am J Physiol 265: 176-182.
5. BRISTOW MR, MINOBE W, RASMUSSEN R, HERSHBERGER RB, HOFFMAN BB, 1988. Alpha-1 adrenergic receptors in the nonfailing and failing human heart. J Pharmacol Exp Ther 247: 1039-1045.
6. CLERK A, BOGOYEVITCH MA, FULLER SJ, LAZOU A, PARKER PJ, SUGDEN PH, 1995. Expression of protein kinase C isoforms during cardiac ventricular development. Am J Physiol 269: H1087-H1097.
7. DALLMAN MJ, LARSEN CP, MORRIS PJ, 1991. Cytokine gene transcription in vascularised organ grafts: analysis using semiquantitative polymerase chain reaction. J Exp Med 174: 493-496.
8. DE BELDER AJ, RADOMSKI MW, WHY HJF, RICHARDSON PJ, BUCKNALL CA, SALAS E, MARTIN JF, MONCADA S, 1993. Nitric oxide synthase activities in human myocardium. Lancet 341: 84-85.
9. DZAU VJ, 1992. Autocrine and paracrine mechanisms in the pathophysiology of heart failure. Am J Cardiol 70: 4C-11C.
10. 2+ mediated through α-and β-adrenoceptors. Circ Res 62: 247-265.
11. EVANS HG, LEWIS JM, SHAH AM, 1993. Interleukin-1β modulates myocardial contraction via dexamethasone sensitive production of nitric oxide. Cardiovasc Res 27: 1486-1490.
12. FINKEL MS, ODDIS CV, JACOB TD, WATKINS SC, HATTLER BG, SIMMONS RL, 1992. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 257: 387-389.
13. FLEMING JW, WISLER PL, WATANABE AM, 1992. Signal transduction by Gproteins in cardiac tissues. Circulation 85: 420-433.
14. 2+ in cardiac myocytes. Circulation 71: 870-882.
15. GREEN LC, WAGNER DA, 1982. Analysis of nitrate, nitrite, and (15N) nitrate in biological fluids. Anal Biochem 126: 131-138.
16. 1-adrenergic agonists as a primary response gene in cultured rat cardiac myocytes. J Biol Chem 269: 26227-26233.
17. HASKING GL, ESLER MD, JENNINGS GL, BURTON D, JOHNS JA, KORNER PI, 1986. Norepinephrine spillover to plasma in patients with congestive heart failure: Evidence of increased overall and cardiorenal sympathetic nervous activity. Circulation 73: 615-621.
18. HENRICH CJ, SIMPSON PC, 1988. Differential acute and chronic response of protein kinase C in cultured neonatal rat heart myocytes to α1 -adrenergic and phorbol ester stimulation. J Mol Cell Cardiol 20: 1081-1085.
19. HODENPUD JD, CAMPBELL SM, MENDELSON DJ, 1989. Interleukin-1-induced myocardial depression in an isolated beating heart preparation. J Heart Transplant 8: 460-464.
20. IKEDA U, SHIMADA K, 1994. Nitric oxide release from rat aortic smooth muscle cells is not attenuated by angiotensin converting enzyme inhibitors. Eur J Pharmacol 269: 319-323.
21. IKEDA U, MAEDA Y, KAWAHARA Y, YOKOYAMA M, SHIMADA K, 1995. Angiotensin II arguments cytokine-stimulated nitric oxide synthesis in rat cardiac myocytes. Circulation 92: 2683-2689.
22. IKEDA U, YAMAMOTO K, ICHIDA M, OHKAWA F, MURATA M, IIMURA O, KUSANO E, ASANO Y, SHIMADA K, 1996. Cyclic AMP augments cytokine-stimulated nitric oxide synthesis in rat cardiac myocytes. J Mol Cell Cardiol 28: 789-795.
23. KAMITANI T, IKEDA U, MUTO S, KAWAKAMI K, NAGANO K, TSURUYA Y, OGUCHI A, YAMAMOTO K, HARA Y, KOJIMA T, MEDFORD RM, SHIMADA K, 1992. Regulation of Na, K-ATPase gene expression by thyroid hormone in rat cardiocytes. Circ Res 71: 1457-1464.
24. Kobayashi E, Nakano H, Morimoto M, Tamaoki T, 1989. Calphostin C (UCN-1028C), a novel microbial compound, is a highly potent and specific inhibitor of protein kinase. C. Biochem Biophys Res Commun 159: 548-533.
25. KOIDE M, KAWAHARA Y, TSUDA T, YOKOYAMA M, 1993. Cytokine-induced expression of an inducible type of nitric oxide synthase gene in cultured vascular smooth muscle cells. FEBS Lett 318: 213-217.
26. LEIER CV, BINKLEY PF, CODY RJ, 1990. α-Adrenergic component of the sympathetic nervous system in congestive heart failure. Circulation 82 [Suppl. I]: I-68-I-76.
27. LEVINE TB, FRANCIS GS, GOLDSMITH SR, SIMON AB, COHN JN, 1982. Activity of the sympathetic nervous system and renin-angiotensin system assessed by plasma hormone levels and their relation to hemodynamic abnormalities in congestive heart failure. Am J Cardiol 49: 1659-1666.
28. MONCADA S, PALMER RMJ, HIGGS FA, 1991. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 43: 109-140.
29. NATHAN C, XIE Q, 1994. Regulation of biosynthesis of nitric oxide. J Biol Chem 269: 13725-13728.
30. PARRILLO JE, 1993. Pathogenetic mechanisms of septic shock. N Engl J Med 328: 1471-1477.
31. PINSKY DJ, CAI B, YANG X, RODRIGUEZ C, SCIACCA RR, CANNON PJ, 1995. The lethal effects of cytokine-induced nitric oxide on cardiac myocytes are blocked by nitric oxide synthase antagonism or transforming growth factor β. J Clin Invest 95: 677-685.
32. ROBERTS A, VODOVOTZ BY, ROCHE NS, SORN MB, NATHAN CF, 1992. Role of nitric oxide in antagonistic effects of transforming growth factor-β and interleukin-1β on the beating rate of cultured cardiac myocytes. Mol Endocrinol 6: 1921-1930.
33. SADOSHIMA J, IZUMO S, 1993. Signal transduction pathways of angiotensin II-induced c-fos gene expression in cardiac myocytes in vitro. Circ Res 73: 424-438.
34. 2+-independent nitric oxide synthase in the myocardium. Br J Pharmacol 105: 575-580.
35. SHINDO T, IKEDA U, OHKAWA F, KAWAHARA Y, YOKOYAMA M, KASAHARA T, SHIMADA K, 1995. Nitric oxide synthesis in cardiac myocytes and fibroblasts by inflammatory cytokines. Cardiovosc Res 29: 813-819.
36. 1-adrenoceptor densities in different mammalian species. Br J Pharmacol 107: 1185-1188.
37. THOMAS JA, MARKS BH, 1978. Plasma norepinephrine in congestive heart failure. Am J Cardiol 41: 233-243.
38. TSUJINO M, HIRATA Y, IMAI T, KANNO K, EGUCHI S, ITO H, MARUMO F, 1994. Induction of nitric oxide synthase gene by interleukin-1β in cultured rat cardiocytes. Circulation 90: 375-383.
39. UNGUREANU-LONGROIS D, BALLIGAND JL, KELLY RA, SMITH TW, 1995. Myocardial contractile dysfunction in the systemic inflammatory response syndrome: role of a cytokine-inducible nitric oxide synthase in cardiac myocytes. J Mol Cell Cardiol 27: 155-167.
40. WEISENSEE D, BEREITER-HAHN J, SCHOEPPE W, LÖW-FRIEDRICH I, 1993. Effects of cytokines on the contractility of cultured cardiac myocytes. Int J Immunopharmacol 51: 581-587.
41. WINLAW DS, SMYTHE GA, KEOGH AM, SCHYVENS CG, SPRATT PM, 1994. Increased nitric oxide production in heart failure. Lancet 344: 373-374.
42. YAMAMOTO K, IKEDA U, SEINO Y, TSURUYA Y, OGUCHI A, OKADA K, ISHIKAWA S, SAITO T, KAWAKAMI K, HARA Y, SHIMADA K, 1993. Regulation of Na,K-ATPase gene expression by sodium ions in cultured neonatal rat cardiocytes. J Clin Invest 92: 1889-1895.
43. YANG X, CHOWDHURY N, CAI B, BRETT J, MARBOE C, SCIACCA RR, MICHLER RE, CANON PJ, 1994. Induction of myocardial nitric oxide synthase by cardiac allograft rejection. J Clin Invest 94: 714-721.